News

March 19, 2018March 19, 2018

Increased Levels of Antibodies Against Adalimumab Related to JIA Relapses, Study Finds

News

Patients with juvenile idiopathic arthritis (JIA) receiving treatment with adalimumab (sold as Humira and other brand names) exhibit high levels of antibodies against the therapy, a factor that seems to ... Read more

March 16, 2018March 16, 2018

Researchers Identify Genetic Sequence Linked to Uveitis Risk in Girls with Juvenile Arthritis

News

Nearly one in three children with the most common forms of juvenile idiopathic arthritis develop a visual disorder called uveitis. To better understand the cause of uveitis, researchers in a recent study ... Read more

March 14, 2018March 14, 2018

Early Exposure to Cigarette Smoke, Air Pollution Associated with JIA, Study Finds

News

Exposure to cigarette smoke and harmful particles in the air during pregnancy and after birth were identified as potential risk factors for the development of juvenile idiopathic arthritis (JIA) in ... Read more

March 12, 2018March 12, 2018

Psychotherapy Technique Treats Methotrexate Intolerance in JIA Patients, Study Reports

News

Use of a psychotherapy method effectively reduces symptoms of methotrexate (MTX) intolerance in patients with juvenile idiopathic arthritis (JIA), according to German researchers. The study, “Successful treatment of methotrexate intolerance ... Read more

March 9, 2018March 9, 2018

Subcutaneous Orencia Seen to Alleviate Polyarticular-course JIA Symptoms in Phase 3 Trial

News

Abatacept, marketed as Orencia by Bristol-Myers Squibb, was seen to improve the symptoms of polyarticular-course juvenile idiopathic arthritis (pJIA) in a Phase 3 clinical trial. Additionally, subcutaneous administration of Orencia was ... Read more

March 7, 2018March 7, 2018

RCGD 423 Therapy May Help Avoid Joint Replacements in JA, Other Conditions

News

Researchers have identified a compound that promotes cartilage repair and may be used to treat juvenile arthritis, avoiding the need for joint replacement. The compound, called the Regulator of Cartilage ... Read more

March 5, 2018March 5, 2018

European Survey Reports Gaps in Many Aspects of JIA Patients’ Care

News

Improvements in supportive care and access to more information are needed by juvenile idiopathic arthritis (JIA) patients, based on a survey of a large panel of European patients and their ... Read more

March 2, 2018March 2, 2018

Joint Ultrasound Can Strongly Predict Relapse in Juvenile Arthritis, Study Suggests

News

Abnormalities detected by joint ultrasound can be strong predictors of relapse in clinically inactive patients with juvenile idiopathic arthritis (JIA), a study suggests. Researchers found that patients who had positive ultrasounds ... Read more

February 28, 2018February 28, 2018

Higher Risk of Cancer in JA Patients Not Associated with TNF Inhibitors, Study Finds

News

While a diagnosis of juvenile idiopathic arthritis, pediatric inflammatory bowel disease, or pediatric plaque psoriasis increases the risk of cancer, use of TNF inhibitors do not seem to significantly affect malignancy ... Read more

February 26, 2018February 26, 2018

Kineret, New Therapy for Systemic JIA, Receives Positive Opinion from EU’s CHMP

News

The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended Sobi’s Kineret (anakinra) as a new treatment for systemic juvenile idiopathic arthritis, a condition also known as Still’s ... Read more